Join Tomasz Piec, President of Supervisory Board, and Dominik Lipka, Director of Research and Development, Board Member and let’s discuss the potential opportunities of cooperation.
SyVento offers the development of encapsulated drugs for all kinds of pharmaceutically active ingredients based on various lipid-based formulations including Lipid Nanoparticles (LNP) for RNA.
The Congress brings together the leading companies developing RNA-based therapeutics and is a global platform for advancing scientific and commercial collaborations, as well as sharing the recent advances and challenges of the field.
29 April 2022Let’s meet at Vitafoods 2022
The countdown to the biggest event in the dietary supplement and functional food industry, Vitafoods Europe 2022, has begun. We have...